2025 Investor Attendees
Company Name |
1004 Venture Partners |
AAA Family Office |
Abbvie Ventures c/o DJS |
Almaral |
Almaral |
Andera Partners |
Astellas |
Avant Bio |
Beyond Impact |
Biovision Ventures |
Bootstrap Europe |
Boundless Health Capital |
Chiesi USA |
Circle 7 capital |
Claret Capital Partners |
Crown Global Capital |
CVX Ventures |
Eir Ventures Partners |
Eir Ventures Partners |
Eitri Innovation Center & Health Incubator |
Endeavor Venture Group |
FaaS Capital |
Farvatn |
Fenja Capital |
Fenja Capital |
FLC Investments AS |
Flerie |
Frumtak Ventures |
Fund+ |
Gilde Healthcare |
GrayBella Capital |
Hadean Ventures |
Hadean Ventures AS |
Haukeland University Hospital |
Health Cap |
Heran Partners |
HERAN Partners BV |
Indaco Bio Fund |
Industrifonden |
Industrifonden |
Innovestor Life Science Oy |
Investinor |
Investinor |
Investinor AS |
Investinor AS |
IPF Partners |
Karolinska Development |
Life Science Invest AB |
LU Ventures AB |
Maruho Deutschland GmbH |
Maudsley Enterprise |
Merieux Equity Partners |
Mérieux Equity Partners |
Mérieux Equity Partners |
NLC Ventures BV |
Nordic Science Investments |
Novo Holdings |
Novo Holdings |
Novo Holdings A/S |
Ontogeny / MTI Vekst |
Opulentia Invest AS |
p53 Invest |
Rethink Capital AB |
Rethink Capital AB |
Sandwater |
Sarsia |
Sarsia |
Sarsia Management AS |
Sarsia Management AS |
Sarsia Management AS |
Sarsia Management AS |
Segulah Medical Acceleration |
Segulah Medical Acceleration |
SmiLe Inject Capital |
Sound Bioventures |
Stokke Industri AS |
Sunstone Life Science Ventures |
Tesi |
Torrey Pines Investments |
Trill Impact |
Voima Ventures |
WAVE Equity Partners |
Zcube, Zambon Research Venture |